Belgium· BE-AMP-SAM583226-00
Cresnisol N10E
A aminosäuren product containing glutamic acid, registered in Belgium by Baxter. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Aminosäuren is registered in 11 of 19 countries.
Countries holding a registration under ATC B05BA01 (aminosäuren), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Aminosäuren · ATC B05BA01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Glutamic Acid
- Manufacturer
- Baxter
- Country
- Belgium (BE)
- ATC code
- B05BA01
- ATC class
- Aminosäuren
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for aminosäuren.
Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Aminosäuren · interactions on record
4 records
- 4 moderate
Most severe, free to view
- AmfetamineN06BA01moderate
- DexamfetamineN06BA02moderate
- MetamfetamineN06BA03moderate
- LisdexamfetamineN06BA12moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Aminosäuren in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyGlutaminVerla-Pharm Arzneimittel Gmbh & Co. Kg
- FinlandHypochylinRecip AB
- United KingdomKabiven Peripheral infusion 2.4litre bagsFresenius Kabi Ltd
- NorwayAciglumin NAFKragerø Tablettproduksjon AS
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Germany · Glutamin, Glutamin Verla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/12ce8eb7-0063-4582-94b7-faddaf105b6d GET /v1/drugs/12ce8eb7-0063-4582-94b7-faddaf105b6d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for infusion",
"source": "afmps",
"status": "REVOKED",
"name_en": "Cresnisol N10E",
"name_fr": "Cresnisol N10E",
"name_nl": "Cresnisol N10E",
"amp_code": "SAM583226-00",
"strengths": [
"3.1600",
"3.1600",
"2.5000",
"2.5000",
"3.7700",
"3.7700",
"2.8900",
"2.8900",
"6.2000",
"6.2000",
"7.0200",
"7.0200"
],
"pack_count": 1,
"substances": [
"Glutamic Acid",
"Serine",
"Proline",
"Sodium Acetate Trihydrate",
"Arginine",
"Lysine Acetate",
"Lysine",
"Phenylalanine",
"Glycine",
"Tyrosine",
"Aspartic Acid",
"Valine",
"Histidine",
"Methionine",
"Magnesium Chloride Hexahydrate",
"Alanine",
"Potassium Chloride",
"Isoleucine",
"Sodium Glycerophosphate Hydrate",
"Leucine",
"Threonine",
"Tryptophan"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Amino Acids",
"authorisation_numbers": [
"BE583226"
]
}See everything about aminosäuren.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.